Before the world even imagined that 4 million drug-eluting stents would be available in 36 countries around the world, the founders of MicroPort? were imagining how they would impact the lives of people through technology. Their belief was that these medical technologies must be accessible to everyone.

Relentless innovation has inspired promising product development and initiated strategic investments in emerging scientific platforms. Today, we see a promising path forward, one that addresses the most challenging healthcare issues, while allowing us to explore the ways to accelerate and broaden access to medical technology innovation.